• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院患者感染相关死亡率:临床及抗菌药物管理干预的风险因素与潜在靶点

Infection-Related Mortality in Hospitalized Patients: Risk Factors and Potential Targets for Clinical and Antimicrobial Stewardship Interventions.

作者信息

Alrahmany Diaa, Omar Ahmed F, Alreesi Aisha, Harb Gehan, Ghazi Islam M

机构信息

Pharmaceutical Care Department, Directorate General of Medical Supplies, Ministry of Health, Muscat 3110, Oman.

General Medicine Department, Suhar Hospital, Suhar 8484, Oman.

出版信息

Antibiotics (Basel). 2022 Aug 10;11(8):1086. doi: 10.3390/antibiotics11081086.

DOI:10.3390/antibiotics11081086
PMID:36009955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9405145/
Abstract

Due to resistance and scarcity of treatment options, nosocomial Acinetobacter baumannii infections are associated with significant fatality rates. We investigated the factors contributing to infection-related deaths to develop tailored stewardship interventions that could reduce these high mortality rates. We reviewed the medical records of adult inpatients with A. baumannii infections over two years. Patient demographics and clinical data were collected and statistically analyzed. The study included 321 patients with positive A. baumannii microbiological cultures, with respiratory infections accounting for 58.6%, soft tissues 29.3%, bacteremia 8.6%, urine 2.1%, and others 1.4%. The study population’s median (IQR) age was 62.6 (38.9−94.9) years, and hospital stay was 20 (9.5−40) days. Statistical analysis revealed that various risk factors contribute significantly to high in-hospital all-cause mortality (44%), as well as 14-day and 28-day mortality rates. Deaths increased by a factor of 1.04 with every additional year of age (p = 0.000), admission to the critical care unit (p = 0.000, OR: 2.86), and patients admitted with an infectious diagnosis had nearly three times the mortality rate as those admitted with other diagnoses (p = 0.000, OR: 3.12). Male gender (p < 0.001, OR: 2.14), any comorbid conditions (p = 0.000, OR: 5.29), prolonged hospitalization (>7 days) (p = 0.023, OR: 1.98), and hospital acquisition of infection (p = 0.027, OR: 1.68) were among the most significant predictors of mortality. All variables were investigated for their impact on all-cause, 14-day, and 28-day mortality rates. Improving multidisciplinary infection control practices, regular disinfection of patient care equipment, and optimal intubation practice that avoids unnecessary intubation are necessary interventions to reduce infection-related mortality rates. Better antibiotic selection and de-escalation, shorter hospital stays whenever possible, prompt medical stabilization of comorbid conditions, and fewer unnecessary admissions to critical care units will all lead to improved outcomes.

摘要

由于耐药性以及治疗选择的匮乏,医院获得性鲍曼不动杆菌感染与显著的死亡率相关。我们调查了导致感染相关死亡的因素,以制定有针对性的管理干预措施,从而降低这些高死亡率。我们回顾了两年内成年鲍曼不动杆菌感染住院患者的病历。收集了患者的人口统计学和临床数据并进行了统计分析。该研究纳入了321例鲍曼不动杆菌微生物培养阳性的患者,其中呼吸道感染占58.6%,软组织感染占29.3%,菌血症占8.6%,尿路感染占2.1%,其他占1.4%。研究人群的年龄中位数(四分位间距)为62.6(38.9 - 94.9)岁,住院时间为20(9.5 - 40)天。统计分析表明,各种风险因素对高院内全因死亡率(44%)以及14天和28天死亡率有显著影响。年龄每增加一岁,死亡风险增加1.04倍(p = 0.000),入住重症监护病房(p = 0.000,比值比:2.86),因感染诊断入院的患者死亡率几乎是因其他诊断入院患者的三倍(p = 0.000,比值比:...

相似文献

1
Infection-Related Mortality in Hospitalized Patients: Risk Factors and Potential Targets for Clinical and Antimicrobial Stewardship Interventions.住院患者感染相关死亡率:临床及抗菌药物管理干预的风险因素与潜在靶点
Antibiotics (Basel). 2022 Aug 10;11(8):1086. doi: 10.3390/antibiotics11081086.
2
Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.多重耐药和广泛耐药鲍曼不动杆菌医院感染与高死亡率相关:儿科重症监护病房的回顾性研究。
BMC Infect Dis. 2020 Aug 12;20(1):597. doi: 10.1186/s12879-020-05321-y.
3
Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.快速诊断与抗菌药物管理的整合可改善抗生素耐药革兰氏阴性菌血症患者的结局。
J Infect. 2014 Sep;69(3):216-25. doi: 10.1016/j.jinf.2014.05.005. Epub 2014 May 17.
4
[Factors associated with mortality in Acinetobacter baumannii infected intensive care unit patients].[鲍曼不动杆菌感染的重症监护病房患者的死亡相关因素]
Mikrobiyol Bul. 2012 Apr;46(2):335-7.
5
Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control.通过抗菌药物管理和感染控制在重症监护病房控制地方性多重耐药鲍曼不动杆菌
Korean J Intern Med. 2016 Mar;31(2):367-74. doi: 10.3904/kjim.2015.178. Epub 2016 Feb 15.
6
Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit.外科重症监护病房中克隆性多重耐药鲍曼不动杆菌感染暴发的流行病学、临床及经济学评估
Infect Control Hosp Epidemiol. 2007 Nov;28(11):1247-54. doi: 10.1086/521660. Epub 2007 Sep 6.
7
Infections in Hospitalized Patients, Treatment Outcomes.住院患者的感染、治疗结果。
Antibiotics (Basel). 2021 May 25;10(6):630. doi: 10.3390/antibiotics10060630.
8
[Risk factors and resistance patterns of invasive infection in Children].[儿童侵袭性感染的危险因素及耐药模式]
Zhonghua Er Ke Za Zhi. 2022 Aug 2;60(8):762-768. doi: 10.3760/cma.j.cn112140-20220502-00404.
9
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.分析 ICU 患者下呼吸道感染的鲍曼不动杆菌分离株的表型和分子特征。
Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15.
10
Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study.多药耐药血流感染、尿路感染和外科部位医院感染的鲍曼不动杆菌和铜绿假单胞菌患者在埃塞俄比亚西北部 Felegehiwot 转诊医院住院:一项横断面研究。
BMC Infect Dis. 2020 Jan 30;20(1):92. doi: 10.1186/s12879-020-4811-8.

引用本文的文献

1
Phenotypic Characterization of and Mutants of 5075: Impacts on Growth, Biofilm Formation, and Tazobactam Response.5075的 和 突变体的表型特征:对生长、生物膜形成及他唑巴坦反应的影响
Antibiotics (Basel). 2025 Aug 9;14(8):816. doi: 10.3390/antibiotics14080816.
2
Eravacycline Treatment for Carbapenem-Resistant in Lung Transplant Recipients: A Real-World Retrospective Study.依拉环素治疗肺移植受者耐碳青霉烯菌感染:一项真实世界回顾性研究。
Infect Drug Resist. 2025 Aug 16;18:4125-4139. doi: 10.2147/IDR.S529016. eCollection 2025.
3
Potential of Cannabidiol (CBD) to overcome extensively drug-resistant Acinetobacter baumannii.大麻二酚(CBD)克服广泛耐药鲍曼不动杆菌的潜力。
BMC Complement Med Ther. 2025 Aug 15;25(1):308. doi: 10.1186/s12906-025-05056-w.
4
Green-Synthesized Zinc Oxide Nanoparticles for Acinetobacter baumannii Control: A Review of Plant-Based Approaches.用于控制鲍曼不动杆菌的绿色合成氧化锌纳米颗粒:基于植物方法的综述
Cureus. 2025 May 5;17(5):e83506. doi: 10.7759/cureus.83506. eCollection 2025 May.
5
The intricacies of : a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications.……的复杂性:对一种多重耐药病原体及其临床意义和影响的多方面综合综述。 (注:原文开头部分不完整,翻译出来的句子也有部分成分缺失,不太能构成完整通顺的表述)
Front Microbiol. 2025 May 12;16:1565965. doi: 10.3389/fmicb.2025.1565965. eCollection 2025.
6
A decade of genomic and phenotypic adaptation of carbapenem-resistant .十年的耐碳青霉烯类药物的基因组和表型适应性
Front Cell Infect Microbiol. 2025 Apr 30;15:1527488. doi: 10.3389/fcimb.2025.1527488. eCollection 2025.
7
Bacteremia in the Gulf Cooperation Council Region: A Review of the Literature 2013-2023.海湾合作委员会地区的菌血症:2013 - 2023年文献综述
Infect Drug Resist. 2025 May 7;18:2329-2355. doi: 10.2147/IDR.S497241. eCollection 2025.
8
Analyzing Clinical Parameters and Bacterial Profiles to Uncover the COPD Exacerbations: A Focus on Intensive Care Unit Challenges.分析临床参数和细菌谱以揭示慢性阻塞性肺疾病急性加重:聚焦重症监护病房的挑战
Medicina (Kaunas). 2025 Apr 5;61(4):669. doi: 10.3390/medicina61040669.
9
An Immunoinformatics-Based Multi-Peptide Vaccine Provides Antibody-Mediated Protection Against Infection.一种基于免疫信息学的多表位疫苗提供抗体介导的抗感染保护。
Vaccines (Basel). 2025 Feb 25;13(3):236. doi: 10.3390/vaccines13030236.
10
Prevalence and Antibiogram Pattern of from 2013 to 2023 in a Tertiary Care Hospital in the Western Region of Saudi Arabia.2013年至2023年沙特阿拉伯西部地区一家三级护理医院的[具体内容缺失]的患病率及抗菌谱模式
Antibiotics (Basel). 2025 Mar 7;14(3):274. doi: 10.3390/antibiotics14030274.

本文引用的文献

1
Device-Associated Hospital-Acquired Infections: Does Active Surveillance With Bundle Care Offer a Pathway to Minimize Them?与设备相关的医院获得性感染:主动监测结合集束化护理能否提供将其降至最低的途径?
Cureus. 2021 Nov 7;13(11):e19331. doi: 10.7759/cureus.19331. eCollection 2021 Nov.
2
Infections in Hospitalized Patients, Treatment Outcomes.住院患者的感染、治疗结果。
Antibiotics (Basel). 2021 May 25;10(6):630. doi: 10.3390/antibiotics10060630.
3
Is Polymicrobial Bacteremia an Independent Risk Factor for Mortality in Bacteremia?polymicrobial菌血症是菌血症患者死亡的独立危险因素吗?
J Clin Med. 2020 Jan 6;9(1):153. doi: 10.3390/jcm9010153.
4
Estimating extra length of stay and risk factors of mortality attributable to healthcare-associated infection at a Chinese university hospital: a multi-state model.估算中国大学附属医院医疗相关感染所致额外住院时间和死亡风险因素:多状态模型。
BMC Infect Dis. 2019 Nov 20;19(1):975. doi: 10.1186/s12879-019-4474-5.
5
Risk factors for endemic Acinetobacter Baumannii colonization: A case-case study.地方性鲍曼不动杆菌定植的危险因素:病例对照研究。
Am J Infect Control. 2019 Nov;47(11):1294-1297. doi: 10.1016/j.ajic.2019.04.179. Epub 2019 Jun 26.
6
Risk Factors for Mortality in Children with Bacteremia in South Korea: The Role of Carbapenem Resistance.韩国菌血症儿童死亡的危险因素:碳青霉烯类耐药的作用。
Microb Drug Resist. 2019 Oct;25(8):1210-1218. doi: 10.1089/mdr.2018.0465. Epub 2019 May 22.
7
Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.鲍曼不动杆菌、铜绿假单胞菌和肺炎克雷伯菌引起的碳青霉烯类和多黏菌素耐药菌血症的流行率和 30 天全因死亡率:长达十年趋势的描述。
Int J Infect Dis. 2019 Aug;85:10-15. doi: 10.1016/j.ijid.2019.05.004. Epub 2019 May 14.
8
Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia.社区获得性和医院获得性鲍曼不动杆菌菌血症的临床特征和结局。
J Microbiol Immunol Infect. 2019 Oct;52(5):796-806. doi: 10.1016/j.jmii.2019.03.004. Epub 2019 Apr 12.
9
Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis.碳青霉烯类耐药鲍曼不动杆菌感染患者死亡的预测因素:系统评价和荟萃分析。
Am J Infect Control. 2019 Sep;47(9):1140-1145. doi: 10.1016/j.ajic.2019.03.003. Epub 2019 Apr 17.
10
Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit.烧伤病房暴发期间多重耐药鲍曼不动杆菌医院感染的发生率、危险因素和结局。
Int J Infect Dis. 2019 Feb;79:179-184. doi: 10.1016/j.ijid.2018.11.371. Epub 2018 Dec 6.